This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Interactions

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Erythromycin is a very widely used antibiotic and is a substrate and inhibitor of cytochrome P450 (CYP3A) enzymes.

Important interactions involving erythromycin/ other macrolides are listed in Appendix 1 of the British National Formulary. The following are not comprehensive lists.

  • the following should not be co-administered with erythromycin: amisulpride, simvastatin, ergotamine, dihydroergotamine, tolterodine, cisapride, pimozide, terfenadine and mizolastine
  • erythromycin may increase serum concentrations of CYP metabolised drugs including: atorvastatin, bromocryptine, carbamazepine, cilostazole, cyclosporin, clozapine, midazolam, phenytoin, quinidine, tacrolimus, rifabutin, theophylline*, valproate, alfentanil, zopiclone, warfarin and digoxin
  • increased erythromycin levels may occur with other CYP3A inhibitors, such as ‘azole’ antifungals, some calcium channel blockers (diltiazem, verapamil), anti-HIV protease inhibitors (e.g. amprenavir, ritonavir, saquinavir)

*theophylline also decreases erythromycin levels

Notes:

  • cytochrome P450 inhibition caused by macrolides may have a slow onset and persist for several days after cessation of treatment
  • erythromycin can increase the ECG QT interval and may rarely be associated with arrhythmias, such as torsades de pointes
    • risk is increased when erythromycin is co-administered with other drugs that increase QT interval and with type 1(a) and type III anti-dysrhythmics (e.g. disopyramide, quinidine, amiodarone)
    • avoid co-administration of drugs which increase QT interval and have pharmacokinetic interactions with erythromycin (e.g. mizolastine, cisapride, terfenadine)

Reference:

  1. Current Problems in Pharmacovigilance 2006;31:1-12.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.